A large British study published on Wednesday found Regeneron Pharmaceuticals Inc’s COVID-19 antibody cocktail reduces deaths in hospitalised patients who have not mounted their own antibody response.

Regeneron COVID-19 therapy cuts deaths among hospitalised patients who lack antibodies: Study

India has given emergency use authorization for a COVID-19 antibody-drug cocktail developed by Roche and Regeneron, expanding its arsenal of drugs to battle a massive second wave of infections.

India approves Roche/Regeneron antibody cocktail to treat COVID-19

Regeneron is pursuing US approval for its COVID-19 monoclonal antibody cocktail as a preventative treatment after it helped cut the risk of symptomatic infections in households where someone else is ill, the US drugmaker said on Monday.

Regeneron to seek US approval for COVID-19 cocktail to be used for prevention